Trifluridine
Viroptic, Lonsurf (trifluridine) is a small molecule pharmaceutical. Trifluridine was first approved as Viroptic on 1982-01-01. It is used to treat herpetic keratitis, infectious keratoconjunctivitis, and virus diseases in the USA. It has been approved in Europe to treat colorectal neoplasms.
| Trade Name | Lonsurf |
|---|---|
| Common Name | Trifluridine |
| Indication | colorectal neoplasms, herpetic keratitis, infectious keratoconjunctivitis, virus diseases |
| Drug Class | Antivirals, antineoplastics (uridine derivatives) |
